A61K 38/40
Transferrins
Official title: Transferrins, e.g. lactoferrins, ovotransferrins
A61K38/40 (Transferrins) appears on 349 US grants and 711 published applications in this corpus.
Search patents in A61K- Granted patents
- 349
- Published applications
- 711
- Assignees
- 327
- Inventors
- 1,178
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 6 | 0 |
| 1994 | 3 | 0 |
| 1995 | 5 | 0 |
| 1996 | 5 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 11 | 5 |
| 2002 | 4 | 10 |
| 2003 | 6 | 16 |
| 2004 | 5 | 24 |
| 2005 | 1 | 21 |
| 2006 | 10 | 21 |
| 2007 | 10 | 37 |
| 2008 | 9 | 20 |
| 2009 | 10 | 26 |
| 2010 | 8 | 41 |
| 2011 | 21 | 38 |
| 2012 | 21 | 35 |
| 2013 | 20 | 38 |
| 2014 | 15 | 26 |
| 2015 | 13 | 42 |
| 2016 | 18 | 26 |
| 2017 | 21 | 36 |
| 2018 | 16 | 21 |
| 2019 | 13 | 20 |
| 2020 | 13 | 30 |
| 2021 | 12 | 30 |
| 2022 | 8 | 34 |
| 2023 | 12 | 42 |
| 2024 | 11 | 30 |
| 2025 | 16 | 25 |
| 2026 | 12 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition and method for a prebiotic delivery system targeted to probiotic bacteria15 Sep 2026US 12,734,248 B2Technion Research & Development Foundation Limited
- Ovotransferrins for use in the treatment of iron deficiency anaemia28 Jul 2026US 12,691,144 B2Bioseutica B.V.
- Methods and compositions for treating mucosal tissue disorders21 Jul 2026US 12,685,755 B2The University of North Carolina at Chapel Hill
- Nutritional composition for improving immune fitness21 Jul 2026US 12,685,768 B2N. V. Nutricia
- Composition and method for a prebiotic delivery system targeted to probiotic bacteria30 Jun 2026US 12,667,622 B2Technion Research & Development Foundation Limited
- Composition for use in treatment and/or prevention of chronic kidney disease complications, kidney disorder progression inhibitor, sarcopenia progression inhibitor, and anemia progression inhibitor17 Sep 2026US 2026/0273027 A1Tohoku University
- Uses of Compositions Comprising a Prebiotic Component10 Sep 2026US 2026/0263505 A1Mead Johnson Nutrition Company
- Uses of fgf21 fusion proteins3 Sep 2026US 2026/0256885 A1Ampsource Biopharma Shanghai Inc.
- Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes3 Sep 2026US 2026/0256888 A1University of Massachusetts
- Prophylaxis of neonatal escherichia coli sepsis3 Sep 2026US 2026/0256893 A1The Children's Mercy Hospital
Most cited
By later US patents
- Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis165US 6,716,813 B2House Ear Institute · 2004
- Transfection reagents155US 7,479,573 B2Invitrogen Corporation · 2009
- Methods and compositions to treat myocardial conditions129US 7,294,334 B1Advanced Cardiovascular Systems, Inc. · 2007
- Compositions and methods for treating wounds93US 5,591,709 ALife Medical Sciences, Inc. · 1997
- Transfection reagents74US 7,166,745 B1Invitrogen Corporation · 2007